These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 3338121)

  • 1. Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure.
    Kasiske BL; O'Donnell MP; Garvis WJ; Keane WF
    Circ Res; 1988 Feb; 62(2):367-74. PubMed ID: 3338121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats.
    Kasiske BL; O'Donnell MP; Cleary MP; Keane WF
    Kidney Int; 1988 Mar; 33(3):667-72. PubMed ID: 3367557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lipids in progressive glomerular disease.
    Keane WF; Kasiske BL; O'Donnell MP
    Adv Exp Med Biol; 1987; 223():81-7. PubMed ID: 3447453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular sclerosis in Wistar rats: analysis of its variable occurrence after unilateral nephrectomy.
    Grond J; van Goor H; Erkelens DW; Elema JD
    Br J Exp Pathol; 1986 Aug; 67(4):473-9. PubMed ID: 3741773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lipids in the pathogenesis of glomerulosclerosis in the rat following subtotal nephrectomy.
    Rayner HC; Ross-Gilbertson VL; Walls J
    Eur J Clin Invest; 1990 Feb; 20(1):97-104. PubMed ID: 2108041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dietary protein and captopril on glomerular permselectivity in rats with unilateral nephrectomy.
    Cartwright ME; Jaenke RS
    Lab Invest; 1988 Oct; 59(4):492-9. PubMed ID: 2459500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for glomerular injury in rats with genetic hypertension.
    O'Donnell MP; Kasiske BL; Keane WF
    Am J Hypertens; 1989 Jan; 2(1):9-13. PubMed ID: 2914086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin retards the progression of established glomerular disease in obese Zucker rats.
    O'Donnell MP; Kasiske BL; Kim Y; Schmitz PG; Keane WF
    Am J Kidney Dis; 1993 Jul; 22(1):83-9. PubMed ID: 8322799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High protein intake accelerates glomerulosclerosis independent of effects on glomerular hemodynamics.
    O'Donnell MP; Kasiske BL; Schmitz PG; Keane WF
    Kidney Int; 1990 May; 37(5):1263-9. PubMed ID: 2345425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury.
    Tolins JP; Raij L
    Hypertension; 1990 Oct; 16(4):452-61. PubMed ID: 2210813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats.
    O'Donnell MP; Kasiske BL; Katz SA; Schmitz PG; Keane WF
    Hypertension; 1992 Nov; 20(5):651-8. PubMed ID: 1428116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
    Remuzzi A; Puntorieri S; Battaglia C; Bertani T; Remuzzi G
    J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hyperlipidemia on glomerular sclerosis in unilateral nephrectomized rats.
    Miyata J; Takebayashi S
    Acta Pathol Jpn; 1987 Sep; 37(9):1433-9. PubMed ID: 3687427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined antihypertensive and lipid-lowering therapy in experimental glomerulonephritis.
    Rubin R; Silbiger S; Sablay L; Neugarten J
    Hypertension; 1994 Jan; 23(1):92-5. PubMed ID: 8282335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of heparin on the glomerular structure and function of remnant nephrons.
    Ichikawa I; Yoshida Y; Fogo A; Purkerson ML; Klahr S
    Kidney Int; 1988 Nov; 34(5):638-44. PubMed ID: 3199677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats.
    O'Donnell MP; Kasiske BL; Daniels FX; Keane WF
    Diabetes; 1986 Sep; 35(9):1011-5. PubMed ID: 3743905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive therapy must control glomerular hypertension to limit glomerular injury.
    Anderson S; Rennke HG; Brenner BM
    J Hypertens Suppl; 1986 Dec; 4(5):S242-4. PubMed ID: 3553475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Evidence for involvement of macrophages and lipids.
    van Goor H; Fidler V; Weening JJ; Grond J
    Lab Invest; 1991 Jun; 64(6):754-65. PubMed ID: 2046327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome.
    Harris KP; Purkerson ML; Yates J; Klahr S
    Am J Kidney Dis; 1990 Jan; 15(1):16-23. PubMed ID: 2294729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the unique susceptibility of deep cortical glomeruli of maturing kidneys to severe focal glomerular sclerosis.
    Ikoma M; Yoshioka T; Ichikawa I; Fogo A
    Pediatr Res; 1990 Sep; 28(3):270-6. PubMed ID: 2235126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.